Thursday 21st November 2019 |
Text too small? |
Maxigesic painkiller manufacturer AFT Pharmaceuticals is starting to deliver on the growth strategy funded by its 2015 NZX listing, with sales in South East Asia rocketing ahead in the first six months of this year and in line with company expectations in the six months to Sept. 30. While growth...
Read the full story at BusinessDesk
https://businessdesk.co.nz/article/aft-pharmaceuticals-starts-to-hit-its-straps
No comments yet
June 4th Morning Report
General Capital Welcomes the Deposit Compensation Scheme
AGL - Accordant Group FY25 Annual Report
Chorus submits 2024 fibre regulatory report
May 30th Morning Report
May 29th Morning Report
RAK - Rakon FY2025 Financial Results
WHS - The Warehouse Group appoints Group Chief Executive Officer
General Capital Dividend Reinvestment Plan
FPH - Record full-year revenue result for FPH